An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against...

Area of Science:

• Mycology
• Vaccinology
• Computational Biology

Background:

• Cryptococcosis, caused by Cryptococcus neoformans and Cryptococcus gattii, is a life-threatening fungal infection with limited treatment options and no available vaccines.
• The infection primarily affects the lungs and brain, leading to pneumonia and meningitis, with untreated cryptococcal meningitis having a near 100% mortality rate.

Purpose of the Study:

• To design and computationally evaluate a polyvalent multiepitope subunit vaccine against Cryptococcosis.
• To identify and characterize highly antigenic epitopes from virulent proteins of C. neoformans and C. gatti for vaccine development.

Main Methods:

• Integrated bioinformatics approaches were used to identify and analyze key virulent proteins (Heat shock transcription factor and Chaperone DnaK).
• In silico methods including antigenicity prediction, transmembrane topology screening, allergenicity and toxicity assessments, and molecular docking were employed.
• Two vaccine constructs were designed, incorporating adjuvants and linkers, and their interactions with Toll-like receptors (TLRs) were evaluated using molecular dynamics simulations and MM-PBSA calculations.

Main Results:

• The designed vaccine constructs demonstrated high antigenicity, non-toxicity, solubility, stability, and compatibility with TLRs.
• Molecular docking and simulations indicated strong binding affinity and stabilizing properties of Vaccine Construct V1 against TLR9.
• Both vaccine constructs showed a significant number of interchain hydrogen bonds with TLR9, suggesting effective immune activation.

Conclusions:

• The study presents promising in silico evidence for a novel polyvalent multiepitope subunit vaccine against C. neoformans and C. gattii.
• The developed vaccine constructs show potential for combating cryptococcosis, warranting further in vivo validation.
• These findings represent a significant step towards developing effective therapeutic and preventative strategies for cryptococcosis.